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PHYSICIANS’ ATTITUDES AND PRACTICES REGARDING THE CARE OF PATIENTS WITH 
CHRONIC NONCANCER PAIN. Anita R. Chandrasena and M. C. Reid. Department of Internal 
Medicine, Yale University, School of Medicine, New Haven, CT. 
Chronic noncancer pain (CNCP) is common in primary care and often treated with opioid analgesics, but 
information regarding primary care providers’ (PCPs) attitudes and practices in the care of patients with CNCP 
is lacking. We determined PCPs prior training in CNCP and assessed their levels of comfort caring for CNCP 
patients, prescribing opioid analgesics, and diagnosing/managing opioid analgesic misuse (OAM). 
Participants included resident physicians (RPs) and attending physicians (APs) at a primary care clinic 
affiliated with an urban teaching hospital. A self-administered questionnaire was used to obtain information on 
PCPs’ demographic status, prior training in the management of CNCP and use of opioids. We measured PCPs’ 
levels of comfort caring for patients with CNCP and prescribing opioid analgesics, and determined their self- 
rated ability to diagnosis OAM. Open-ended questions were used to ascertain how PCPs diagnose and manage 
OAM. 
Of the 57 PCPs surveyed, 53 (93.0%) responded. A majority was male (54.7%), the mean number of years 
(range) since medical graduation was 4.3 (1-33) and 71.7% were RPs. A minority of PCPs reported high levels 
of comfort when caring for patients with CNCP (41.5%) or when prescribing opioid analgesics (30.2%). APs 
expressed greater comfort than RPs in both areas (66.7% vs. 31.6%, P=0.020, and 53.3% vs. 21.5%, P=0.021, 
respectively). Only 20.8% of PCPs rated their ability to diagnose OAM as high. APs were more likely to rate 
their ability to diagnose OAM as high when compared with RPs (40.0% vs. 18.4%, P=0.100). Formal (vs. no) 
training in CNCP was correlated with higher comfort levels in the care of CNCP patients (53.3% vs. 26.1%, 
P=0.046). Formal training in CNCP and prescribing opioid analgesics had no significant impact on PCP 
comfort in the prescription of opioid analgesics and ability to diagnose OAM. Commonly reported patient 
behaviors cited as evidence of OAM included multiple requests for early refills (60.4%), reports of lost/stolen 
medications (39.6%), and requests for specific drugs or formulations (39.6%). Strategies commonly used to 
manage patients suspected of OAM included confronting patients to discuss concerns about OAM (69.8%), 
implementing opioid contracts in those lacking contracts (24.5%), and stopping opioid medications (17.0%). 
Most participants felt uncomfortable providing care for patients with CNCP, prescribing opioid analgesics 
and diagnosing OAM. PCPs currently used a broad array of methods to diagnose and manage OAM. These 
data suggest that further education and the establishment of formal guidelines could help PCPs better manage 
patients with chronic noncancer pain. 
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INTRODUCTION 
Chronic noncancer pain (CNCP) is common in the U.S. population and is associated with 
substantial morbidity and healthcare costs (1). The World Health Organization defines “chronic” 
or “persistent pain” as pain that is present “most of the time” for a period of six months or more 
(2). More than 75 million people present to practicing physicians each year with some form of 
persistent or recurrent pain, and the prevalence of CNCP in primary care practices is estimated to 
be between 5 and 33%, with an average prevalence of 22% (2, 3). The medical and social 
consequences that result from CNCP are numerous. When compared to the general population, 
patients with CNCP are more likely to report impaired quality of life in the areas of physical, 
social, and psychological well being, have higher rates of depression and anxiety, and are five 
times more likely to utilize health care services when compared to patients without chronic pain 
(4). 
Management strategies for CNCP typically include a broad spectrum of both 
nonpharmacologic and pharmacologic interventions. Patients with CNCP often require an 
individualized treatment regimen. However, many physicians often start with nonpharmacologic 
methods including stretching or strengthening exercises with physical therapy focusing on 
“reconditioning, stretching and pain reduction techniques” (4). In addition, most providers 
believe that providing education regarding the possible long-term nature of a patient’s 
symptoms, the physical and physiological basis of pain, and the possible consequences of pain, is 
of great importance (4). In addition to these tools, physicians managing patients with CNCP 
often utilize the expertise of psychologists, occupational therapists, and practitioners of 
alternative medicine. While these therapeutic interventions may improve patients’ level of pain 
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and assist in increasing their functional status, pharmacological therapies are also often required 
for long-term management. 
A variety of pharmacological treatments are used in the care of patients with CNCP. The 
specific type of medication used often depends upon the etiology of the patient’s pam and their 
comorbid medical status. Nonsteroidal anti-inflammatory drugs (NSAIDs) are often used as a 
first-line therapy. Many other classes of medications including acetaminophen, aspirin, 
tramadol, selective-serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs), 
neuroleptics, and opioid agonists are also used in the treatment of patients with CNCP (4). 
The use of opioid analgesics in the treatment of CNCP continues to be an actively 
debated issue. Initially, the long-term treatment of pain with opioids was discouraged by pain 
experts because of concerns over their side effects (e.g., respiratory depression, sedation, 
tolerance) and the potential for addiction. Over the past two decades there has been a new 
willingness to prescribe opioid analgesics to patients with CNCP. This change in clinical practice 
is believed to be due, in part, to the successful experience of treating cancer patients with opioid 
medications. In addition, several case series have demonstrated the safety and relative efficacy of 
using this class of medications in the treatment of CNCP (5,6). Many experts believe that even 
though “there have been no long-term controlled studies investigating the efficacy of the chronic 
use of opioid analgesics for noncancer pain, good relief is generally reported for the majority of’ 
patients with CNCP (4). A major issue related to the prescription of opioids for the long-term 
treatment of CNCP is the potential for physical dependence and the risks of abuse. Physical 
dependence is a physiological response that is characterized by the potential for withdrawal 
symptoms following discontinuation of therapy, dose reduction or administration of an 
antagonist (7). With opioids, physical dependence occurs at different rates for different patients 

and according to Portenoy (7), patients should be presumed to be dependent following repeated 
doses of an opioid after a few days. The difference between analgesic misuse and dependence is 
complicated, especially in regards to opioid analgesics and so standard definitions of substance 
misuse are difficult to apply to patients using this class of drugs. 
Understanding the definitions used by experts to describe various patterns of substance 
use and misuse is of great importance. The terms “physical dependence” and “tolerance” are 
considered normal consequences of long-term opioid use, however, they are often incorrectly 
classified as components of addiction. Addiction is defined as a “neurobehavioral syndrome 
with genetic and environmental influences that results in psychological dependence on the use of 
substance for their psychic effects and is characterized by compulsive use despite harm (1).” 
Despite the previously noted concerns regarding the use of opioid medications in the care 
of patients with CNCP, use of opioid analgesics in this patient population is becoming 
increasingly common. Physician surveys conducted in 1989 (8) and 1993 (9) indicated that 
between 62 and 83% of pain specialists maintained at least some of their patients on chronic 
opioids for CNCP. However, the surveys also demonstrated that a substantial number of 
physicians are also reluctant to treat their CNCP patients with opioid analgesics. Reasons for the 
physicians’ reluctance included concerns regarding the unproven efficacy of opioid medications 
in the treatment of CNCP and the potential for opioid misuse (7). 
According to other studies, the number of internists and non-pain specialists using opioid 
analgesics for the treatment of CNCP is also increasing (10). In a study of physicians’ attitudes 
and practices regarding the treatment of CNCP with opioid analgesics, Turk found that the 
prescription of long-term opioids is widespread (9). In this study, 6962 physicians were 
randomly sampled from different geographic regions and different specialties and surveyed to 
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obtain information regarding their number of years in practice, number of chronic pain patients 
treated, frequency of prescription of long-term opioids, concerns about opioids, goals of 
treatment, perceptions regarding their education in the area of prescribing opioids and concerns 
about regulation. Rheumatologists and general practitioners were most likely to prescribe long¬ 
term opioids and were more likely to look for symptomatic (subjective) improvement rather than 
functional (objective) improvements. This survey also revealed that many physicians felt their 
education regarding pain evaluation and treatment during both medical school and residency was 
inadequate (9). Most participants felt that the training they received during residency regarding 
the management of CNCP was more useful than the training they received during medical 
school. However, both were described as “less than” satisfactory. In addition, rheumatologists 
were the least satisfied with the training they had received and were also the most likely to 
prescribe opioid analgesics for CNCP. The findings from this survey indicate that greater 
attention needs to be given to covering pain evaluation and treatment during professional 
training. This study also illustrates that the most frequent problems noted by physicians treating 
patients with CNCP were intolerance to side effects, physical tolerance, withdrawal and abuse of 
these medications. Surprisingly, most participants believed that opioid analgesics were actually 
under-utilized and that addiction was over-emphasized. 
A second study evaluated the knowledge of a broad spectrum of health care 
professionals’ by asking providers to rate the accuracy of a series of statements regarding the 
following topics: addiction, pain assessment, and scheduling of drugs (11). In this survey 
respondents (n=686) included physicians, nurses, pharmacists, and medical/nursing students 
from varying hospital settings, practice areas, and countries of origin. Survey questions were 
scored for accuracy with the percentage indicating the percent concordance. The average overall 
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correct score for the sample was 56%, with the physician group scoring the highest. Of the 
physicians, anesthesiologists scored the highest with surgeons scoring the lowest and internal 
medicine physicians falling in the middle. These findings indicate that while the prescription of 
opioids for the management of chronic pain is increasingly common, there are many 
misconceptions regarding these drugs including attitudes that may interfere with “optimal care” 
in areas including the assessment of pain, the pharmacological management of pain and the issue 
of analgesic misuse. The items corresponding with the most divergent opinions among 
participants were related to knowledge involving addiction and the most common misconception 
is that “addiction” to narcotics is far more prevalent among “pain” patients than it really is. 
Greater than three quarters of respondents believed that “25% of patients receiving around the 
clock narcotics become addicted.” The actual incidence of “addiction” is believed to be less than 
1% (11). This indicates that physicians and other health care professionals are likely to fear 
addiction and consequently may be under-treating pain. 
Both of the previously described studies illustrated the deficiencies in medical 
education/training regarding the assessment and treatment of patients with CNCP. The studies 
described conflicting theories regarding experience/education level and perceptions regarding 
chronic pain and opioid analgesic misuse. While both studies provided information regarding 
misconceptions health care professionals may have about the prescription of opioid analgesics 
and the risks of opioid analgesic misuse (OAM), both fail to provide information about the 
practical implications of these misconceptions. It is important to understand how the 
deficiencies in medical education translate into the care of the patient and to understand if there 
is a relationship between greater exposure to training in the topics of chronic pain and opioid 
analgesics and greater comfort in treating CNCP patients with opioids. Prior studies have not 
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attempted to examine the relationship between formal training and comfort in these areas. 
Demonstrating that formal training is associated with increased comfort in caring for CNCP 
patients on opioids would provide strong support for increasing the amount of formal training 
that health care providers receive in this area. However, if formal training is not correlated with 
increased comfort in the care of patients with CNCP using opioids, there would be evidence to 
indicate that the current methods to train physicians need to be updated and changed in order to 
provide physicians with the skills they need to better manage this group of patients. 
Although prior studies focused on a broad spectrum of clinicians, they did not focus on 
obtaining data from primary care providers (PCPs). Because the number of PCPs dealing with 
the issue of opioid analgesic misuse is increasing (10), it is becoming increasingly important to 
appreciate their understanding of these issues and to learn what deficiencies exist in their training 
and education. In addition, looking at residents in internal medicine at differing stages in their 
training may also be useful in providing information about what specific steps need to be taken 
to improve medical education. 
An additional challenge faced by health care providers in the care of patients with CNCP 
is establishing a firm diagnosis of OAM among patients suspected of misusing these 
medications. The diagnosis of OAM in patients with CNCP is a difficult task and a standardized 
set of tools to diagnose OAM has not yet been established. Patterns of behavior indicative of 
OAM such as escalating use, “drug seeking” behavior, and doctor shopping are discussed in the 
literature (12). Escalating use is one of the signals of OAM that physicians are taught to look 
for. However, it is important to note that the undertreatment of pain by underprescribing or by 
underestimating the magnitude of symptoms may also lead to escalating use. While all of these 
behaviors may be indicative of OAM, the complex psychosocial nature of CNCP makes it 
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difficult to make broad, general statements pertaining to OAM. Although experts have 
advocated that certain patient behaviors (e.g. escalating use, forged/stolen prescription, repeated 
requests for early refills) are indicative of OAM, their validity (as a diagnostic tool) has not been 
established. Because there is no consensus regarding how physicians should diagnose OAM, it 
is likely that physicians use a broad array of methods in their practice. Documenting this lack of 
uniformity would provide strong support for the development of a standardized clinical tool for 
the diagnosis of OAM. Studies are therefore needed to determine what methods clinicians use to 
identify OAM in their CNCP patients who receive opioid analgesics. In addition, such a survey 
may provide potentially valuable approaches for the identification of individuals at risk for OAM 
that could be subsequently evaluated in future studies. 
Once the diagnosis of OAM is made, PCPs must then decide how to best manage their 
patients’ pain complaints and their medication misuse. It is believed that pain cannot be 
adequately managed when complicated by misuse and many experts believe that it may even be 
worsened (13). Some of the methods to manage OAM in patients with CNCP described in the 
literature include referrals to specialty pain clinics, establishing closer and more intense clinic 
contact, adjusting medications, adding adjunctive treatments, reviewing clinic policy with 
patients and referring to substance abuse treatment programs (13,14,15). Another commonly 
cited method to manage these patients is to utilize an opioid contract. Opioid contracts serve to 
inform patients about the risks and benefits of opioid use and the conditions under which these 
medications will be prescribed. In addition, many pain experts believe that a lifetime or current 
substance use disorder should not preclude the use of opioid analgesics for the treatment of 
CNCP. However, they recommend that closer and more careful monitoring of medication use 
should occur (13). Although there are a broad array of methods to manage OAM, there are no 
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established guidelines outlining what steps PCPs should take to effectively manage their patients. 
Identifying the methods that PCPs use to manage patients with suspected OAM is important for 
several reasons. First, it is important to document what PCPs actually do when faced with the 
problem of OAM. Second, it is important to learn if PCPs are informed about what options are 
available to them as future research could aim to provide information to PCPs regarding the best 
ways to deal with OAM. Finally, it is important to ensure that patients are being treated 
adequately as now their PCPs must deal with two very complex problems, chronic pain and 
OAM. 
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STATEMENT OF PURPOSE 
Hypotheses: 
• Levels of comfort in the care of patients with CNCP, in the prescription of opioid 
analgesics, and in the ability to diagnose OAM are associated with level of medical 
training. 
• PCPs use a broad spectrum of tools when identifying OAM and when managing 
patients who are suspected of OAM. 
Purpose: 
• To determine the proportion of PCPs with formal training in the areas of CNCP and 
prescription of opioid analgesics. 
• To assess PCPs’ self-reported level of comfort in the areas of CNCP, the prescription 
of opioid analgesics, and in the diagnosis of OAM. 
• To evaluate the effects of formal training in the areas of CNCP and the prescription of 
opioid analgesics on self-reported level of comfort in (1) providing care to patients 
with CNCP, (2) prescribing opioid analgesics, and (3) diagnosing OAM. 
• To identify patient behaviors that PCPs feel are indicative of OAM. 
• To identify strategies PCPs use to manage patients suspected of OAM. 
9 

METHODS 
Overview 
This research project consisted of a cross-sectional study where a questionnaire was 
administered to PCPs who provided longitudinal care at the Primary Care Center (PCC) at Yale- 
New Haven Hospital (YNHH), in New Haven, CT. The study was conducted at the PCC, which 
is an urban hospital-based primary care clinic serving approximately 7,000 patients. This 
practice serves as a training site for internal medicine residents at the Yale University School of 
Medicine. The PCC at YNHH was chosen as the site of this study because of the diversity of the 
patient population, the prevalence of CNCP patients who receive long-term opioid analgesics, 
and the range of experience of PCC providers. 
Study Participants & Corresponding Eligibility Criteria 
1. Resident physicians (RP)—All categorical internal medicine residents who have their 
continuity clinic at the PCC at YNNH were asked to participate. The eligibility 
criteria included completion of medical school with an MD degree and willingness to 
participate. 
2. Attending physicians (AP)—All internal medicine physicians who have completed 
residency training and are affiliated with the PCC at YNHH were asked to participate. 
The eligibility criteria included completion of medical school and residency training 
and willingness to participate. 
3. Nurse practitioners—All nurse practitioners providing longitudinal care to patients at 
the PCC were asked to participate. The eligibility criteria included completion of 
nursing school with an APRN degree and willingness to participate. There was only 
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one nurse practitioner in the practice. This participant’s responses were included with 
the RP group. 
Survey and Sampling Procedure 
Participants were approached during their continuity clinics and invited to complete the 
CNCP Education and Attitude Survey (Appendix 1). Providers were asked to complete the 
survey either at the beginning of their clinic session or in between patient visits throughout the 
day. The survey took between five and ten minutes to complete. 
Description of Sur\>ey Instrument 
• Demographic data: We obtained information on participants’ demographic status 
including gender, type of degree earned, and number of years post-graduation 
(Questions 1-3). 
• Formal training: We inquired about participants’ prior formal training in the care 
of patients with CNCP and the prescription of opioid analgesics. Response 
categories for these questions included yes/no and for those who had received 
formal training response categories also included formal lecture, conference, 
seminar, workshop or other. Participants were asked to rate the usefulness of 
further training in these areas. A 5-point Likert scale was used and response 
categories for these questions included: Extremely valuable = 1, Very valuable = 
2, No opinion = 3, Somewhat valuable = 4, Not valuable = 5 (Questions 4-5). 
• Self-reported comfort: Participants were asked to rate their level of comfort in 
providing health care for patients with CNCP and for patients on opioid 
analgesics. A 5-point Likert scale was used and response categories for these 
questions included: Extremely comfortable = 1, Very comfortable = 2, No 
opinion = 3, Somewhat uncomfortable = 4, Very uncomfortable = 5 (Questions 6- 
7). 
• Self-rated ability to diagnose QAM: Participants were asked to assess their ability 
to diagnose OAM using a 5-point Likert scale, response categories included: 
Excellent = 1, Good = 2, Fair = 3, Poor = 4, Extremely poor = 5 (Question 8). 
• Tools and techniques: Open-ended questions were used to obtain information 
regarding specific patient behaviors or actions that participants felt suggested 
OAM. A second open-ended question was used to obtain information about how 
participants manage their patients once the diagnosis of OAM is made (Question 
9-11). 
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• Discharge of patient from care: Participants were asked if they have ever 
discharged a patient from their care due to concern for substance misuse/abuse 
(Question 12). 
• Experience with CNCP in personal acquaintances: Participants were asked if they 
have dealt with chronic pain in their personal lives (e.g. have they themselves had 
CNCP or known anyone personally who has had CNCP), (Question 13). 
Data Entry 
Data were recorded directly onto survey forms (see Appendix 1), and then entered into 
Epi Info. All of the computer data were manually checked against the survey forms, and any 
errors were immediately corrected. 
Data Analysis 
'j 
To test for group differences, % -tests were used for categorical variables and t-tests were 
used for continuous variables. A p-value less than 0.05 was considered statistically significant. 
All of the statistical analyses were completed on Epi Info. 
Responses to open-ended questions were reviewed and coded independently by two 
reviewers and disagreements were resolved by consensus. Similar responses were assembled 
into discrete categories (e.g. refusing trials of nonopioids and missing scheduled appointments 
were included under noncompliant behaviors). 
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RESULTS 
Demographics 
Of 57 PCPs surveyed, 53 (93.0%) responded. A majority was male (54.7%), the 
mean (range) number of years since medical graduation was 4.3 (1-33) and 71.7% were 
RPs. 
Formal training 
The majority of participants (56.6%) reported formal training in the area of CNCP, 
(Table 1). Of the RPs, 50.0% reported formal training in CNCP, whereas 73.3% of APs reported 
training, however, this difference was not statistically significant (P=0.123). The majority of 
participants (64.2%) desired further training in CNCP regardless of prior formal training; APs 
were slightly more likely to desire further training (73.3% vs. 60.5%, P=0.381) than RPs. 
Formal training in the prescription of opioid analgesics was less common, as 47.4% of RPs and 
53.3% of APs reported formal training in this area (P=Q.696). The majority of PCPs (64.2%) 
desired further training in prescription of opioids regardless of prior formal training; RPs were 
slightly more likely than APs (65.8% vs. 60.0%, P=0.692), to desire further training (Table 1). 
Self-rated comfort in the care of patients with CNCP 
Less than half of the participants (41.5%) rated their comfort in the care of patients with 
CNCP as extremely or very comfortable. Residents had higher mean scores (2.5 vs. 3.2, 
P=0.022), where higher scores represent greater discomfort (Table 2). APs were more likely to 
rate their comfort level as extremely or very comfortable (66.7% vs. 31.6%, P=0.020), as 
compared to RPs (Table 3). Those who received formal training in CNCP were more likely to 
have higher comfort (extremely comfortable or very comfortable) levels than those who did not 
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(53.3% vs. 26.1%, P=0.046). In addition, those who received formal training in the prescription 
of opioid analgesics were also more likely to have higher comfort levels (50.0% vs. 33.3%, 
P=0.218) than those who did not receive formal training in this area (Table 3). Participants who 
had a personal acquaintance with CNCP were somewhat more likely to have expressed higher 
comfort levels (52.3% vs. 34.5%, P=0.206) than those who did not (Table 3). 
Self-rated comfort in the prescription of opioids 
Only 30.2% of participants rated their comfort in their prescription of opioids as 
extremely or very comfortable. RPs had higher mean scores (2.8 vs. 3.5, P=0.025) where higher 
scores represent greater discomfort (Table 2). APs were more likely to rate their comfort level as 
extremely or very comfortable (53.3% vs. 21.5%, P=0.021) compared to RPs (Table 4). Those 
who received formal training in CNCP were more likely to have higher comfort levels in the 
prescription of opioid analgesics (36.7% vs. 21.8%, P=0.241) compared to those who did not 
(Table 4). There was no difference in comfort in the prescription of opioids between those who 
received formal training in the prescription of opioids and those who did not (30.8% vs. 29.6%, 
P-0.928). In addition, those who had a personal acquaintance with CNCP were slightly more 
likely to report higher comfort levels than those who did not (38.1% vs. 24.1%, P=0.288). 
Self-rated ability to diagnose opioid analgesic misuse 
Only 20.8% of participants rated their ability to diagnose OAM as excellent or good. 
RPs had higher mean scores in self-rated ability to diagnose OAM (2.5 vs. 2.9, P=0.046) where 
higher scores represent greater discomfort (Table 2). APs were more likely to rate their ability to 
diagnose OAM as excellent or good (40.0% vs. 18.4% P=0.100), compared to RPs (Table 5). 
APs were more likely to rate their diagnostic ability as excellent or good (40.0% vs. 22.6%, 
P=0.100), when compared to RPs. Those who received formal training in CNCP were more 
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likely to rate their diagnostic ability as excellent or good (30.0% vs. 17.4%, P=0.290), compared 
to those who did not received formal training in this area (Table 5). Those who received formal 
training in the prescription of opioid analgesics were slightly more likely to rate their diagnostic 
ability as excellent or good (26.9% vs. 22.2%, P=0.691). Participants who had a personal 
acquaintance with CNCP were more likely to rate their diagnostic ability as excellent or good 
(28.6% vs. 24.1%, P=0.724) compared to those who did not. Comfort levels in CNCP were 
correlated with self-rated diagnostic ability, as those who rated their comfort as high (extremely 
or very comfortable) were also more likely to rate their diagnostic ability as high (40.9% vs. 
12.9%, P=0.020) compared to those who did not rate their comfort in CNCP as high. The same 
relationship holds true for comfort in the prescription of opioid analgesics and diagnostic ability 
(43.8% vs. 16.2%, P= 0.032). 
Tools providers use to diagnose and manage OAM 
Listed below are the responses participants provided when asked about 
behaviors/activities they look for when they are concerned about OAM (Table 6). Commonly 
reported patient behaviors cited as evidence of OAM included multiple requests for early refills 
(60.4%), reports of lost/stolen medications (39.6%), requests for specific drugs or formulations 
(39.6%), use of multiple sources to obtain opioids (34.0%), and increasing medication 
requirements (24.5%). Less commonly reported patient behaviors cited as evidence of OAM are 
also listed in Table 6. 
Responses participants provided when asked how they manage OAM are listed in Table 
7. Strategies commonly used to manage patients suspected of OAM included confronting 
patients to discuss concerns about OAM (69.8%), implementing opioid contracts in those lacking 
contracts (24.5%), discontinuing opioid medications (17.0%), and documenting OAM via 
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pharmacies and/or other providers (15.1%). Less commonly cited management techniques are 
also listed in Table 7. 
Other Outcomes 
The majority of participants (56.6%) prescribed opioid analgesics for the treatment of 
CNCP (Table 1), and there was no statistically significant difference between APs and RPs 
(53.3% vs. 57.9%, P=0.763). 
Fewer than half of participants (39.6%) had a personal acquaintance with CNCP, APs 
were more likely to have an acquaintance with CNCP (66.7% vs. 28.9%, P=0.021) than RPs 
(Table 1). 
The majority of participants (50.9%) reported having discontinued prescribing opioid 
analgesics to CNCP patients, APs were more likely to have discontinued treatment with opioids 
than RPs (73.3% vs. 42.1%, P=0.03Q), (Table 1). 
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DISCUSSION 
Exposure to CNCP occurs either through formal means throughout medical training or 
through personal means (i.e. through clinical experiences). The majority of PCPs in our study 
reported prior formal training in the area of CNCP either through formal lectures, conferences or 
seminars. Approximately 40% of all PCPs have either personally experienced or have had an 
acquaintance who has experienced chronic pain, and APs were more likely to have had a 
personal acquaintance with CNCP. Despite having some prior formal training in the 
management of CNCP, the majority of PCPs (regardless of level of training) reported placing 
high value on further training in this area. This is consistent with previous research which 
indicated that most providers were dissatisfied with the training they received about CNCP 
during medical school or residency (9). 
Exposure to formal training in the prescription of opioid analgesics is less common than 
training in CNCP, as less than 50% of all participants received formal training in the prescription 
of opioid analgesics. However, a significant proportion of participants reported placing high 
value on further training in the prescription of opioid analgesics, regardless of prior training. 
This finding suggests a greater need for future training and attention in this area. 
Exposure to CNCP and training in the prescription of opioid analgesics is related to self- 
reported comfort in caring for patients with CNCP, the prescription of opioid analgesics and self- 
rated ability to diagnose OAM. The majority of participants are uncomfortable providing care 
for patients with CNCP. However, APs reported greater comfort than RPs. It is likely that a 
relationship exists between prior experience caring for patients with CNCP and comfort in this 
area. In addition, those who reported formal training in CNCP also reported higher comfort 
levels than those who did not. This implies that the training providers have received thus far 
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have led to subjective improvements in their ability to care for these patients. Interestingly, 
exposure to personal acquaintances with CNCP did not have a significant impact in this area. 
Therefore, both level of medical training and formal training in the care of patients with CNCP 
have led to subjective improvements in provider comfort in caring for patients with CNCP. 
The majority of participants expressed discomfort in prescribing opioid analgesics. 
However, APs were more comfortable than RPs in this clinical task. In addition, formal training 
in the prescription of opioid analgesics did not have a significant impact on participants’ comfort 
levels. Neither did exposure to personal acquaintances with CNCP. These data indicate that 
comfort with prescribing opioid analgesics is more dependent upon provider level of medical 
training with medications rather than formal training or nonclinical experiences. Although there 
is literature available which outlines treatment strategies utilizing opioid analgesics for the 
treatment of CNCP, there have been no well-established guidelines published regarding the 
prescription of opioid analgesics. As more research in this area becomes available, more 
education will be provided to PCPs. With new guidelines and improved training, providers are 
likely to feel more comfortable in their ability to prescribe opioid analgesics. 
The majority of participants were uncomfortable diagnosing OAM, and level of training 
was not a factor associated with this outcome. As described in previous work, more experienced 
providers did not differ from less experienced ones (11). Other researchers have supported the 
idea that the experience of APs might be offset by more and better education in CNCP received 
by more recent graduates of medical school (11). However, in our sample there was no 
statistically significant difference between APs and RPs in their exposure to formal training in 
the areas of CNCP and the prescription of opioid analgesics. Therefore, the explanation 
regarding the quantity of training is not valid. The explanation regarding the quality of 
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education, however, may be more valid. In recent years, the attention paid to CNCP and the 
recognition of OAM in patients treated with opioid analgesics has increased, as has the amount 
of research in these areas. Perhaps this has led to improvements in the level of education 
provided to PCPs in more recent years. 
Although there have been some improvements in the quality of education received as 
more information becomes available, further progress still needs to be made as formal training in 
caring for patients with CNCP, and in prescribing opioid analgesics, did not significantly 
improve provider comfort levels. These data indicate that the diagnosis of OAM continues to be 
an area of discomfort and none of the exposures are correlated with comfort regardless of the 
training received. As a result, further education and experience at all levels of training might be 
useful. Perhaps it is the absence of guidelines providing PCPs with standardized and practical 
tools to diagnose OAM that has left most PCPs feeling ill-equipped to deal with this complex 
issue. In the future, it will be interesting to see if the establishment of clear and objective 
guidelines to diagnose OAM will lead to improvements in physician comfort in the diagnosis of 
OAM (11). 
The diagnosis of OAM in patients treated with opioid analgesics for CNCP continues to 
be an area of uncertainty for providers. When asked what behaviors providers look for in 
patients when OAM is suspected, participants reported a variety of behaviors and activities. The 
lack of consistency in participants’ responses further reinforces our hypothesis that there is great 
uncertainty among PCPs in this area. According to Portenoy, a two-step approach should be 
adopted when attempting to diagnose OAM (16). A physician must (1) notice “aberrant drug- 
related behaviors” in patients and (2) find the “diagnosis that best explains the occurrence of the 
aberrant behaviors” and then decide whether those behaviors are consistent with the “diagnosis 
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of addiction or if they are associated with other psychiatric, social or behavioral problems” (16). 
Many of the recommendations made in the literature in regards to this topic are often vague and 
open to interpretation. And so it is not surprising that providers utilize a broad array of 
techniques to screen for abuse, as many of the articles in the available literature fail to outline 
specific behaviors that providers should look for. 
However, some of the most commonly reported behaviors in our study were also reported 
in previous work (7,12,13,14). They included requests for early refills, reports of lost or stolen 
prescriptions, the use of multiple sources for obtaining prescriptions and escalating medication 
use. 
One article that does describe specific behaviors to look for is by Portenoy (7). In this 
work a core group of “aberrant drug-related phenomena” are outlined and include “loss of 
control over drug use, compulsive drug use, and continued use despite harm.” In addition, lists 
of “predictive aberrant behaviors” and “less predictive aberrant behaviors” are included. 
However, it is important to note that these lists are based on expert opinion and have not been 
validated. Some of the “predictive” behaviors include selling prescribed drugs, prescription 
forgery and stealing/borrowing drugs from others. A few of the “less predictive” behaviors 
include aggressive complaining about the need for more drug, drug hoarding during periods of 
decreased symptoms, requests for specific drugs, unsanctioned dose escalation or other non- 
compliance with therapy on one to two occasions, and unapproved use of the drug to treat 
symptoms other than pain (7). Interestingly, some of the behaviors described as “less predictive” 
of misuse in this study were the same behaviors providers in our study mentioned as indicators of 
abuse. They include requests for specific drugs or formulations, displays of hostile/angry 
behaviors when discussing pain/drug regimens, and noncompliance with scheduled 
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appointments. This discrepancy cannot be resolved as further studies are needed to validate the 
behaviors listed above. 
One of the indicators of OAM described by participants was a history of current or past 
abuse. This is supported by several authors who identified patients treated with opioid 
analgesics with a personal or family history of substance abuse as being at increased risk for 
future OAM or abuse of other substances (17). Some authors even argue that patients with a 
prior history of substance abuse should not be prescribed opioid analgesics for CNCP (12). Even 
though most authors disagree with the above statement, some argue that a personal (but not 
family) history is more prevalent in patients diagnosed with OAM as compared with controls 
(13). However, others state that a history of prior drug or alcohol abuse did not predict “who 
would later become opiate abusers” (14). The literature does not support nor refute whether a 
prior personal or family history of substance abuse is indicative of future abuse and the questions 
remains if this history should be used to screen for current OAM. 
Kouyanou et. al. state that the incidence of depression in groups with medication abuse 
and dependence is elevated (18). In addition, one participant in our survey stated that symptoms 
of depression were included in their screen for OAM. This is an interesting issue as it is believed 
that symptoms of depression and anxiety modulate an individual’s perception of pain (19). The 
question remains if the depressed patient is truly misusing their opioid analgesics and using their 
pain medications to treat other symptoms or if their perception of pain has increased and they are 
requiring more medications to help to cope with their pain. 
Some of the behaviors participants listed in our study that were novel included refusal of 
trials of nonopioid medications, lack of objective signs/symptoms, unclear etiology of pain, 
reports of allergies to nonopioid medications, failure to attend specialty referral appointments, 
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and violation of an opioid contract (Table 5). All of these behaviors represent new ways to 
approach the problem and perhaps when combined with more commonly used techniques may 
be effective ways to determine if a patient is misusing their opioid analgesics. Future research in 
this area is needed to determine whether the patient behaviors identified in this study are 
independent predictors of OAM. 
Once the diagnosis of OAM is made, the PCP has to then decide how to confront the 
issue and manage the patient’s pain complaints. The majority of PCPs sought to confront the 
patient directly and discuss his/her concerns with the patient. Other frequently reported activities 
included discussing and formally establishing an opioid contract with patients without existing 
contracts, discontinuing the prescription of opioids, documenting OAM through confirming 
misuse with pharmacies and/or other providers, and outlining and reviewing terms of opioid 
contracts but continuing to prescribe opioids for those who had a contract. Some of the actions 
outlined in the literature include some of the above mentioned actions. Chabal et. al., describe 
the following steps to be taken after OAM is suspected: reassess patient’s condition, provide 
closer/more intense clinic contact if needed, adjust medications, add adjunctive treatments and 
review clinic policy on opioid use (14). Although these steps were described for a pain clinic, 
they are likely to be applicable to a primary care practice that is capable of providing these 
services. 
Referral to specialty pain clinics is one way PCPs manage their patients with CNCP on 
opioid analgesics. Chabal states that “most of the patients using opiates were referred to the pain 
clinic from primary care clinics solely for reasons related to their use of opiates.” He continues 
to say that in most cases these patients were a source of conflict in their former clinic and that 
95% of these “problem patients” were effectively managed on opioid analgesics in the pain clinic 
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setting (14). Three participants in our study reported that they refer to specialty care including 
substance abuse treatment programs, psychiatrists and pain specialists. Chabal’s data imply that 
referral to specialty pain clinics is another viable method to assist PCPs in managing their 
patients treated with opioid analgesics for CNCP when OAM is suspected (14). This as well as 
the other management techniques discussed above should be examined more closely in future 
studies to determine their efficacy. 
There are several limitations of this study that deserve comment. The first of the 
limitations is the small sample size. However, it is important to note that this is the first study to 
examine these specific issues with PCPs, and future studies can be conducted with larger 
samples in order to study these topics more closely. A second limitation is the small number of 
APs compared to RPs, which was difficult to avoid given the nature of the study site. Being a 
continuity clinic for a teaching hospital, the number of RPs is expected to be greater than the 
number of APs. A third limitation is the specific nature of the patient population. The PCC 
patient population is an urban one and the unique characteristics of the patients are likely to 
influence the responses of the participants. As a result, the findings of this study may not be 
generalizable to other primary care practices. Future research can work to improve the 
generalizability by sampling PCPs from a variety of practice settings. A fourth limitation is that 
the reliability of participant responses was not established. This also needs to be studied in 
future work. Finally, failure to inquire about the usefulness of the training that participants have 
received prevents us from strengthening the relationships between formal training and comfort 
levels in caring for patients with CNCP, the prescription of opioids, and diagnosing OAM. 
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CONCLUSION 
In conclusion, our findings indicate that most PCPs lack confidence in the care of patients 
with CNCP, the prescription of opioid analgesics and the diagnosis of OAM. While the care of 
patients with CNCP using opioid analgesics has been examined in prior studies, this is the first 
project to focus on PCPs at all levels of post-graduate training. Also, this was the first study that 
attempted to examine the relationships between formal training and PCP comfort in caring for 
patients with CNCP, the prescription of opioid analgesics and the diagnosis of OAM. Our 
findings indicate that provider comfort in caring for patients with CNCP is related to previous 
experience and formal training, whereas comfort in the prescription of opioid analgesics is 
related to previous experience alone. Comfort in the diagnosis of OAM was not related to either. 
In addition, a substantial majority of participants believe that further education in these areas is 
needed during medical training. These data support previous research which found that the 
education physicians receive in the areas studied needs to be improved in order to provide 
physicians with the training needed to successfully care for their patients with CNCP using 
opioid analgesics. 
Furthermore, our study has shown that PCPs use a broad array of strategies to diagnose 
and manage OAM. Many of the strategies identified in our study have been discussed in the 
literature, along with several others. However, all of these strategies need to be empirically 
tested in order to further assess their utility and clinical application. Finally, future studies are 
needed to define optimal approaches for the management of CNCP, the prescription of opioid 
analgesics, and to develop objective and valid methods for the diagnosis of OAM in order for 
PCPs to manage their patients with greater confidence and success. 
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Table 1. Demographic data and experience with chronic noncancer pain 
Attribute 
AP 
(n=15) 
RP 
(n=38) 
All 
(n=53) 
P- 
value’ 
Male, (%) 46.7 57.9 54.7 0.405 
Years post-graduation ± SD 10.2 ±8.1 2.0±0.9 4.3±5.7 <0.001 
PCPs managing patients with CNCP on 
opioid analgesics, (%) 
53.3 57.9 56.6 0.763 
Formal training in CNCP , (%) 73.3 50.0 56.6 0.123 
Utility of further training in CNCP, (%) 73.3 60.5 64.2 0.381 
Formal training in POA\ (%) 53.3 47.4 49.1 0.696 
Utility of further training in POA, (%) 60.0 65.8 64.2 0.692 
Personal acquaintance with CNCP, ( %) 66.7 28.9 39.6 0.021 
History of discontinuing POA, (%) 73.3 42.1 50.9 0.030 
P-value for test of differences between APs vs. RPs. 
f Chronic noncancer pain. 
+ Prescription of opioid analgesics. 
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Table 2. Mean self-rated comfort levels in chronic noncancer pain, the prescription of 
opioids and the diagnosis of opioid analgesic misuse 
Attribute 
AP 
(n=15) 
RP 
(n=38) 
All 
(n=53) 
p- t 
value* 
Mean self-rated comfort 
in CNCPf ± SD 
2.5±1.1 3.2±0.9 3.0±1.0 0.022 
Mean self-rated comfort in 
POA* ± SD 
2.8±0.9 3.5±1.2 3.3±1.1 0.025 
Mean self-rated ability 
diagnosing GAM55 ± SD 
2.5±0.6 2.9±0.6 2.8±0.7 0.046 
+ P-value for test of differences between APs vs. RPs. 
' Chronic noncancer pain. 
+ Prescription of opioid analgesics. 
5 Opioid analgesic misuse. 
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Table 3. Self-reported comfort in caring for patients with chronic noncancer pain 
Specific characteristic 
High level of comfort 
in caring for patients with 
chronic noncancer pain p-value 
AP vs. RP 66.7% vs. 31.6% 0.020 
Formal (vs. no) training in CNCP' 53.3% vs. 26.1% 0.046 
Formal (vs. no) training in POA* 50.0% vs. 33.3% 0.218 
Personal (vs. no) acquaintance 
with CNCP 
52.3% vs. 34.5% 0.206 
* Includes responses of extremely comfortable or very comfortable vs. no opinion, somewhat uncomfortable, or 
extremely uncomfortable. 
1 Chronic noncancer pain. 
; Prescription of opioid analgesics. 
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Table 4. Self-reported comfort in the prescription of opioid analgesics 
Specific characteristic 
High level of comfort 
in the prescription of 
opioid analgesics p-value 
AP vs. RP 53.3% vs. 21.5% 0.021 
Formal (vs. no) training in CNCP' 36.7% vs. 21.8% 0.241 
Formal (vs. no) training in POA* 30.8% vs. 29.6% 0.928 
Personal (vs. no) acquaintance 
with CNCP 
38.1% vs. 24.1% 0.288 
Includes responses of extremely comfortable or very comfortable vs. no opinion, somewhat uncomfortable, or 
extremely uncomfortable. 
' Chronic noncancer pain. 
1 Prescription of opioid analgesics. 
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Table 5. Self-rated ability to diagnose opioid analgesic misuse 
Specific characteristic 
High self-rated ability 
to diagnose opioid 
analgesic misuse p-value 
AP vs. RP 40.0% vs. 22.6% 0.100 
Formal (vs. no) training in CNCP’ 30.0% vs. 17.4% 0.290 
Formal (vs. no) training in POA1 26.9% vs. 22.2% 0.691 
Personal (vs. no) acquaintance 
with CNCP 
28.6% vs. 24.1% 0.724 
Flight comfort in CNCP 40.9% vs. 12.9% 0.020 
High * comfort in POA 43.8% vs. 16.2% 0.032 
Includes responses of excellent or good vs. fair, poor or extremely poor. 
' Chronic noncancer pain. 
+ Prescription of opioid analgesics. 
5 Includes responses of extremely comfortable or very comfortable vs. no opinion, very uncomfortable, or extremely 
uncomfortable. 
Includes responses of extremely comfortable or very comfortable vs. no opinion, very uncomfortable, or 
extremely uncomfortable. 
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APPENDIX 1 
PHYSICIAN & NURSE PRACTITIONER SURVEY QUESTIONNAIRE 
1. Gender: Male/Female 
2. Type of degree: M.D. Nurse Practitioner Other (please specify) : 
3. What year did you graduate from medical, P.A. or nursing school? _ 
4. Have you had any formal training (such as workshops, noon conferences, etc) in the management of chronic pain? 
YES NO 
4a. If yes, in what setting: Formal lecture 
Conference 
Seminar 
Workshop 
Other (please specify) 
4b. If yes: How valuable would additional training be on this topic? 
1 2 3 4 5 
Extremely Very No opinion Somewhat Not 
valuable valuable valuable valuable 
): How valuable would training on this topic be? 
1 2 3 4 5 
Extremely Very No opinion Somewhat Not 
valuable valuable valuable valuable 
5. Have you had any formal training (such as workshops, noon conferences, etc) in the use of prescription opiates for 
patients with chronic noncancer pain? 
YES NO 
5a. If yes, in what setting: Formal lecture 
Conference 
Seminar 
Workshop 
Other (please specify)_ 
5b. If yes: How valuable would additional training be on this topic? 
I 2 3 4 5 
Extremely Very No opinion Somewhat Not 
valuable valuable valuable valuable 
no: How valuable would training on this topic be? 
1 2 3 4 5 
Extremely Very No opinion Somewhat Not 
valuable valuable valuable valuable 
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6. How comfortable do you feel providing care for patients with chronic non-cancer pain? 
12 3 45 N/A REF 
Extremely Very No Opinion Somewhat Extremely 
Comfortable Comfortable Uncomfortable Uncomfortable 
7. How comfortable do you feel prescribing opiate analgesic medications for patients with chronic noncancer pain? 
1 2 3 4 5 N/A REF 
Extremely Very No Opinion Somewhat Extremely 
Comfortable Comfortable Uncomfortable Uncomfortable 
8. How would you rate your ability to diagnose opiate analgesic misuse in patients with chronic noncancer pain who 
are on opiate medications? 
1 2 3 4 5 
Excellent Good Fair Poor Extremely poor 
9. What behaviors/activities do you look for in chronic noncancer pain patients treated with opioid analgesic 
medications that suggest misuse or abuse of these medications? 
10. What do you do when you suspect opiate misuse or abuse? 
11. What do you say to your patients when you suspect opioid analgesic abuse/misuse? 
12. Have you ever stopped treating (or discharged) a patient from your care because of suspected or proven opioid 
analgesic misuse/abuse? 
YES NO DK REF 
13. Have you or anyone you have personally known(e.g. family members, relatives, friends, acquaintances, etc.) 
experienced chronic noncancer pain? 
YES NO DK REF 
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